Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 205

1.

Retirement age and the age of onset of Alzheimer's disease: results from the ICTUS study.

Grotz C, Letenneur L, Bonsang E, Amieva H, Meillon C, Quertemont E, Salmon E, Adam S; ICTUS/DSA group.

PLoS One. 2015 Feb 25;10(2):e0115056. doi: 10.1371/journal.pone.0115056. eCollection 2015.

2.

Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease.

Dubois B, Chupin M, Hampel H, Lista S, Cavedo E, Croisile B, Tisserand GL, Touchon J, Bonafe A, Ousset PJ, Ait Ameur A, Rouaud O, Ricolfi F, Vighetto A, Pasquier F, Delmaire C, Ceccaldi M, Girard N, Dufouil C, Lehericy S, Tonelli I, Duveau F, Colliot O, Garnero L, Sarazin M, Dormont D; “Hippocampus Study Group”.

Alzheimers Dement. 2015 Jan 14. pii: S1552-5260(14)02856-8. doi: 10.1016/j.jalz.2014.10.003. [Epub ahead of print]

PMID:
25596420
3.

A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles.

Lehmann S, Dumurgier J, Schraen S, Wallon D, Blanc F, Magnin E, Bombois S, Bousiges O, Campion D, Cretin B, Delaby C, Hannequin D, Jung B, Hugon J, Laplanche JL, Miguet-Alfonsi C, Peoc'h K, Philippi N, Quillard-Muraine M, Sablonnière B, Touchon J, Vercruysse O, Paquet C, Pasquier F, Gabelle A.

Alzheimers Res Ther. 2014 Jun 26;6(3):38. doi: 10.1186/alzrt267. eCollection 2014.

4.

Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderly.

Gabelle A, Schraen S, Gutierrez LA, Pays C, Rouaud O, Buée L, Touchon J, Helmer C, Lambert JC, Berr C.

Alzheimers Dement. 2014 Jul 8. pii: S1552-5260(14)00643-8. doi: 10.1016/j.jalz.2014.04.515. [Epub ahead of print]

PMID:
25022539
5.
6.

Consequences of induced hatching plasticity depend on predator community.

Wojdak JM, Touchon JC, Hite JL, Meyer B, Vonesh JR.

Oecologia. 2014 Aug;175(4):1267-76. doi: 10.1007/s00442-014-2962-2. Epub 2014 May 21.

PMID:
24844644
7.

Recommendations for the use of Serious Games in people with Alzheimer's Disease, related disorders and frailty.

Robert PH, König A, Amieva H, Andrieu S, Bremond F, Bullock R, Ceccaldi M, Dubois B, Gauthier S, Kenigsberg PA, Nave S, Orgogozo JM, Piano J, Benoit M, Touchon J, Vellas B, Yesavage J, Manera V.

Front Aging Neurosci. 2014 Mar 24;6:54. doi: 10.3389/fnagi.2014.00054. eCollection 2014.

8.

Understanding the complexities of functional ability in Alzheimer's disease: more than just basic and instrumental factors.

Kahle-Wrobleski K, Coley N, Lepage B, Cantet C, Vellas B, Andrieu S; Plasa DSA Group.

Curr Alzheimer Res. 2014 May;11(4):357-66.

9.

Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study.

Canevelli M, Adali N, Kelaiditi E, Cantet C, Ousset PJ, Cesari M; ICTUS/DSA Group.

Phytomedicine. 2014 May 15;21(6):888-92. doi: 10.1016/j.phymed.2014.01.003. Epub 2014 Feb 16.

10.

A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe : predictors of discontinuation and switch in the ICTUS study.

Gardette V, Lapeyre-Mestre M, Piau A, Gallini A, Cantet C, Montastruc JL, Vellas B, Andrieu S; ICTUS Group.

CNS Drugs. 2014 Feb;28(2):157-70. doi: 10.1007/s40263-013-0133-3.

PMID:
24408842
11.

An overview of the use of music therapy in the context of Alzheimer's disease: a report of a French expert group.

Guetin S, Charras K, Berard A, Arbus C, Berthelon P, Blanc F, Blayac JP, Bonte F, Bouceffa JP, Clement S, Ducourneau G, Gzil F, Laeng N, Lecourt E, Ledoux S, Platel H, Thomas-Anterion C, Touchon J, Vrait FX, Leger JM.

Dementia (London). 2013 Sep;12(5):619-34. doi: 10.1177/1471301212438290. Epub 2012 Mar 28. Review.

PMID:
24337333
12.

Impact of harmonization of collection tubes on Alzheimer's disease diagnosis.

Lehmann S, Schraen S, Quadrio I, Paquet C, Bombois S, Delaby C, Dorey A, Dumurgier J, Hirtz C, Krolak-Salmon P, Laplanche JL, Moreaud O, Peoc'h K, Rouaud O, Sablonnière B, Thouvenot E, Touchon J, Vercruysse O, Hugon J, Gabelle A, Pasquier F, Perret-Liaudet A.

Alzheimers Dement. 2014 Oct;10(5 Suppl):S390-S394.e2. doi: 10.1016/j.jalz.2013.06.008. Epub 2013 Oct 23.

PMID:
24269268
13.

Cognitive frailty: rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group.

Kelaiditi E, Cesari M, Canevelli M, van Kan GA, Ousset PJ, Gillette-Guyonnet S, Ritz P, Duveau F, Soto ME, Provencher V, Nourhashemi F, Salvà A, Robert P, Andrieu S, Rolland Y, Touchon J, Fitten JL, Vellas B; IANA/IAGG.

J Nutr Health Aging. 2013 Sep;17(9):726-34. doi: 10.1007/s12603-013-0367-2.

PMID:
24154642
14.

Biomarkers of Alzheimer's disease: the present and the future.

Lehmann S, Delaby C, Touchon J, Hirtz C, Gabelle A.

Rev Neurol (Paris). 2013 Oct;169(10):719-23. doi: 10.1016/j.neurol.2013.07.012. Epub 2013 Sep 7. Review.

PMID:
24021316
15.

Education modulates the impact of white matter lesions on the risk of mild cognitive impairment and dementia.

Mortamais M, Portet F, Brickman AM, Provenzano FA, Muraskin J, Akbaraly TN, Berr C, Touchon J, Bonafé A, le Bars E, Menjot de Champfleur N, Maller JJ, Meslin C, Sabatier R, Ritchie K, Artero S.

Am J Geriatr Psychiatry. 2014 Nov;22(11):1336-45. doi: 10.1016/j.jagp.2013.06.002. Epub 2013 Sep 8.

PMID:
24021219
16.

The impact of memantine in combination with acetylcholinesterase inhibitors on admission of patients with Alzheimer's disease to nursing homes: cost-effectiveness analysis in France.

Touchon J, Lachaine J, Beauchemin C, Granghaud A, Rive B, Bineau S.

Eur J Health Econ. 2014 Nov;15(8):791-800. doi: 10.1007/s10198-013-0523-y. Epub 2013 Aug 9.

17.

Measuring cognitive change in subjects with prodromal Alzheimer's disease.

Mura T, Proust-Lima C, Jacqmin-Gadda H, Akbaraly TN, Touchon J, Dubois B, Berr C.

J Neurol Neurosurg Psychiatry. 2014 Apr;85(4):363-70. doi: 10.1136/jnnp-2013-305078. Epub 2013 Jul 9.

PMID:
23840054
18.

Behavioral plasticity mitigates risk across environments and predators during anuran metamorphosis.

Touchon JC, Jiménez RR, Abinette SH, Vonesh JR, Warkentin KM.

Oecologia. 2013 Nov;173(3):801-11. doi: 10.1007/s00442-013-2714-8. Epub 2013 Jul 4.

PMID:
23824140
19.

Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force.

Vellas B, Carrillo MC, Sampaio C, Brashear HR, Siemers E, Hampel H, Schneider LS, Weiner M, Doody R, Khachaturian Z, Cedarbaum J, Grundman M, Broich K, Giacobini E, Dubois B, Sperling R, Wilcock GK, Fox N, Scheltens P, Touchon J, Hendrix S, Andrieu S, Aisen P; EU/US/CTAD Task Force Members.

Alzheimers Dement. 2013 Jul;9(4):438-44. doi: 10.1016/j.jalz.2013.03.007.

PMID:
23809364
20.

Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study.

Damian M, Hausner L, Jekel K, Richter M, Froelich L, Almkvist O, Boada M, Bullock R, De Deyn PP, Frisoni GB, Hampel H, Jones RW, Kehoe P, Lenoir H, Minthon L, Olde Rikkert MG, Rodriguez G, Scheltens P, Soininen H, Spiru L, Touchon J, Tsolaki M, Vellas B, Verhey FR, Winblad B, Wahlund LO, Wilcock G, Visser PJ.

Dement Geriatr Cogn Disord. 2013;36(1-2):1-19. doi: 10.1159/000348354. Epub 2013 May 3.

PMID:
23651945
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk